Skip to content
Navigate to homepage - Cerba Research

CerbACT Asia: Immuno-Oncology Center of Excellence

Turn precision medicine into action

When you’re driven to improve cancer patients’ lives, turn to a leader in oncology clinical trial development.

Through CerbACT, our immuno-oncology Center of Excellence, we empower precision medicine research by applying deep and wide biomarker expertise, translational research, and clinical development strategy.

From our purpose-built lab facility in Taiwan, CerbACT Asia supports I/O drug developers globally with cutting edge technology in FCM, histopathology, immunohistochemistry, and NGS sequencing, to turn precision medicine into action.

Our Services

CerbACT is a joint venture between Cerba Research and ACT Genomics, developed to meet the needs of IO drug developers. A synergistic combination of expertise and capabilities to solve precision medicine challenges by advancing your research with a new platform combining deep scientific expertise and technical capabilities. For biotech, pharmaceutical, government, and non-government organizations, CerbACT turns precision medicine innovation into action.

Explore the CerbACT Asia Laboratory

Watch this video for a grand tour of our facility in Taipei in 360° view and discover a short overview of the instruments and technology present to support you in your Immuno-oncology research.

Cerba Research takes you on a 360 degree tour of their research lab in Taiwan

Reach out to our experts and discover how we can help you transform your research and advance health!

Contact Us